Status:
UNKNOWN
To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases
Lead Sponsor:
Sao Thai Duong Joint Stock Company
Collaborating Sponsors:
Big Leap Research
Conditions:
Scalp Dermatitis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Scalp Conditions are common chronic skin inflamations with the occurence rate of 1 - 5 % among the population. TD03 shampoo and TD07 shampoo are widely used to avoid hair loss with successful rate rea...
Detailed Description
Scalp Conditions are common chronic skin inflamations with the occurence rate of 1 - 5 % among the population. TD03 shampoo and TD07 shampoo are widely used to avoid hair loss with successful rate rea...
Eligibility Criteria
Inclusion
- \> 18 years old and signed the ICF.
- Diagnosed with head skin inflamtion with IGA \<= 3.
- Voluntary sign the ICF before any procedures.
- No hypersentivity to the IP.
Exclusion
- Use oral antifungal 1 month prior to the trial participation or topical antifungal 2 weeks prior to the trial participation.
- Suffering chronic or acute diseases that may affect the trial.
Key Trial Info
Start Date :
May 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
366 Patients enrolled
Trial Details
Trial ID
NCT03845348
Start Date
May 22 2019
End Date
June 1 2023
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationa Hospital of Dermatology
Hanoi, Vietnam, 100000